Mesothelioma, Malignant trials recruiting in Washington
All Mesothelioma, Malignant trials nationally
3
Recruiting in Washington
1
Cities with sites
Cities in Washington
Seattle 3
Recruiting trials in Washington
- A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing